Company registration number:
04690746
Dedham Pharm Limited
Unaudited filleted financial statements
30 September 2026
Dedham Pharm Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Dedham Pharm Limited
Directors and other information
|
|
|
|
Directors |
Mr J Kotecha |
|
|
Mrs R Kotecha |
|
|
|
|
|
|
|
Secretary |
Mrs R Kotecha |
|
|
|
|
|
|
|
Company number |
04690746 |
|
|
|
|
|
|
|
Registered office |
54-58 High Street |
|
|
Edgware |
|
|
Middlesex |
|
|
HA8 3EJ |
|
|
|
|
|
|
|
Accountants |
Hindocha Pandit & Co Limited |
|
|
4th Floor Elizabeth House |
|
|
54-58 High Street |
|
|
Edgware |
|
|
Middlesex |
|
|
HA8 3EJ |
|
|
|
Dedham Pharm Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Dedham Pharm Limited
Year ended 30 September 2026
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Dedham Pharm Limited for the year ended 30 September 2026 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the board of directors of Dedham Pharm Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Dedham Pharm Limited and state those matters that we have agreed to state to the board of directors of Dedham Pharm Limited as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Dedham Pharm Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Dedham Pharm Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Dedham Pharm Limited. You consider that Dedham Pharm Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Dedham Pharm Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Hindocha Pandit & Co Limited
Chartered Certified Accountants
4th Floor Elizabeth House
54-58 High Street
Edgware
Middlesex
HA8 3EJ
28 October 2026
Dedham Pharm Limited
Statement of financial position
30 September 2026
|
|
|
2026 |
|
2025 |
|
|
|
|
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
347,444 |
|
348,605 |
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
(
3,664) |
|
(
1,377) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Net current assets |
|
|
343,780 |
|
347,228 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
343,780 |
|
347,228 |
|
|
|
|
|
|
|
|
|
|
|
Accruals and deferred income |
|
|
(
660) |
|
(
660) |
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Net assets |
|
|
343,120 |
|
346,568 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
343,120 |
|
346,568 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
Notes to the financial statements
Dedham Pharm Limited
Year ended 30 September 2026
1.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2026 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Mr J Kotecha |
(
342) |
(
680) |
(
1,022) |
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Mr J Kotecha |
(
342) |
- |
(
342) |
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
For the year ending 30 September 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
28 October 2026
, and are signed on behalf of the board by:
Mr J Kotecha
Mrs R Kotecha
Director
Director
Company registration number:
04690746
The company is a private company limited by shares, registered in England and Wales.